Tolerability, safety and efficacy of a novel phosphate binder VS-505 (AP301): a Phase 2 dose-escalation and dose-ranging study in patients undergoing maintenance hemodialysis.

Autor: Zhuang B; Center for Kidney Disease, Second Affiliated Hospital, Nanjing Medical University, Nanjing, China., Gan L; Department of Nephrology, Peking University People's Hospital, Beijing, China., Liu B; Nephrology Department, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, China., Yuan W; Nephrology Department, Shanghai General Hospital, Shanghai, China., Shi M; Nephrology Department, Renmin Hospital of Wuhan University, Wuhan, China., Peng A; Nephrology Department, Shanghai Tenth Hospital, Shanghai, China., Wang L; Nephrology Department, The Second Hospital of Shanxi Medical University, Taiyuan, China., Chen X; Nephrology Department, Affiliated Hospital of Nantong University, Nantong, China., Liu T; Nephrology Department, Changzhou No. 2 People's Hospital, Changzhou, China., Zhang S; Nephrology Department, Jilin Province People's Hospital, Changchun, China., Wang S; Nephrology Department, Peking University Third Hospital, Beijing, China., Gao Q; Department of Nephrology, Zhongshan Hospital of Xiamen University School of Medicine, Xiamen, China., Wang B; Nephrology Department, The Third Hospital of Hebei Medical University, Shijiazhuang, China., Zheng H; Nephrology Department, The Second Affiliated Hospital of Xingtai Medical College, Xingtai, China., Liu C; Nephrology Department, Northern Jiangsu People's Hospital, Yangzhou, China., Luo Y; Center for Kidney Disease, Second Affiliated Hospital, Nanjing Medical University, Nanjing, China., Ye H; Center for Kidney Disease, Second Affiliated Hospital, Nanjing Medical University, Nanjing, China., Lin H; Nephrology Department, The First Hospital of Dalian Medical University, Dalian, China., Li Y; Department of Nephrology, Zhejiang Provincial People's Hospital, Hangzhou, China., He Q; Department of Nephrology, Zhejiang Provincial People's Hospital, Hangzhou, China., Zheng F; Nephrology Department, The Second Hospital of Dalian Medical University, Dalian, China., Luo P; Nephrology Department, The Second Hospital of Jilin University, Changchun, China., Long G; Department of Nephrology, Tianjin Union Medical Center, Tianjin, China., Lu W; Department of Nephrology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China., Li K; Nephrology Department, The Affiliated Hospital of Guilin Medical University, Guilin, China., Yang J; Center for Kidney Disease, Second Affiliated Hospital, Nanjing Medical University, Nanjing, China., Liu YC; Shanghai Alebund Pharmaceuticals Limited, Shanghai, China., Zhang Z; Shanghai Alebund Pharmaceuticals Limited, Shanghai, China., Li X; Shanghai Alebund Pharmaceuticals Limited, Shanghai, China., Zhang W; Shanghai Alebund Pharmaceuticals Limited, Shanghai, China., Zuo L; Department of Nephrology, Peking University People's Hospital, Beijing, China.

Publikováno v: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2024 Sep 27; Vol. 39 (10), pp. 1649-1661.

[LANTHANUM DEPOSITS AS A RARE DIFFERENTIAL DIAGNOSIS OF VILLOUS ATROPHY].

Autor: Gingold-Belfer R; Division Gastroenterology, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Siterman M; Division Gastroenterology, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel., Goldman S; Division of Nephrology and Hypertension, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel., Hayman Manzur L; Department of Pathology, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel.

Publikováno v: Harefuah [Harefuah] 2024 Nov; Vol. 163 (10), pp. 655-658.

Prospective multicenter study to describe the prevalence, outcomes, and management of phosphate disorders in intensive care patients: Study protocol for part B of the international GUTPHOS study.

Autor: Melchers M; Department of Intensive Care Medicine, Gelderse Vallei Hospital, Ede, the Netherlands; Wageningen University & Research, Division of Human Nutrition and Health, Wageningen, the Netherlands. Electronic address: melchersm@zgv.nl., Kouw IWK; Department of Intensive Care Medicine, Gelderse Vallei Hospital, Ede, the Netherlands; Wageningen University & Research, Division of Human Nutrition and Health, Wageningen, the Netherlands. Electronic address: imre.kouw@wur.nl., Arabi YM; Department of Intensive Care, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia. Electronic address: yaseenarabi@yahoo.com., Casaer MP; Clinical Department and Laboratory of Intensive Care Medicine, KU Leuven, Leuven, Belgium. Electronic address: michael.casaer@uzleuven.be., Cotoia A; Department of Anesthesia and Intensive Care, University Hospital Policlinico of Foggia, Foggia, Italy. Electronic address: antonella.cotoia@unifg.it., Gunst J; Clinical Department and Laboratory of Intensive Care Medicine, KU Leuven, Leuven, Belgium. Electronic address: jan.gunst@kuleuven.be., Malbrain MLNG; First Department of Anesthesiology and Intensive Therapy, Medical University of Lublin, Lublin, Poland; Medical Data Management (Medaman), Geel, Belgium. Electronic address: manu.malbrain@telenet.be., Schaller SJ; Department of Anesthesiology and Intensive Care Medicine (CCM/CKV), Charité - Universitätsmedizin Berlin, Berlin, Germany; Department of Anesthesiology and Intensive Care, School of Medicine and Health, Technical University of Munich, Munich, Germany. Electronic address: stefan.schaller@charite.de., Starkopf J; Department of Anesthesiology and Intensive Care, University of Tartu, Estonia. Electronic address: joel.starkopf@kliinikum.ee., Rehal MS; Perioperative Medicine and Intensive Care (PMI), Karolinska University Hospital, Stockholm, Sweden; Division of Anaesthesia and Intensive Care, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institute, Stockholm, Sweden. Electronic address: martin.sundstrom@gmail.com., Blaser AR; Department of Anesthesiology and Intensive Care, University of Tartu, Estonia; Department of Intensive Care Medicine, Lucerne Cantonal Hospital, Lucerne, Switzerland. Electronic address: annika.reintam.blaser@ut.ee., van Zanten ARH; Department of Intensive Care Medicine, Gelderse Vallei Hospital, Ede, the Netherlands; Wageningen University & Research, Division of Human Nutrition and Health, Wageningen, the Netherlands. Electronic address: zantena@zgv.nl.

Publikováno v: Clinical nutrition ESPEN [Clin Nutr ESPEN] 2024 Oct; Vol. 63, pp. 681-687. Date of Electronic Publication: 2024 Jul 26.

Structural and molecular imaging-based characterization of soft tissue and vascular calcification in hyperphosphatemic familial tumoral calcinosis.

Autor: Sheppard AJ; National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD 20892, United States.; School of Medicine, Louisiana State University Health Shreveport, Shreveport, LA 71103, United States., Paravastu SS; National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD 20892, United States.; University of Missouri - Kansas City School of Medicine, Kansas City, MO 64108, United States., Farhadi F; Department of Radiology and Imaging Sciences, Clinical Center, NIH, Bethesda, MD 20892, United States.; Geisel School of Medicine, Dartmouth, Hanover, NH 03755, United States.; Institute of Nuclear Medicine, Bethesda, MD 20892, United States., Donnelly E; Department of Materials Science and Engineering, Cornell University, Ithaca, NY 14853, United States., Hartley IR; National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD 20892, United States., Gafni RI; National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD 20892, United States., Saboury B; National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD 20892, United States.; Institute of Nuclear Medicine, Bethesda, MD 20892, United States., Collins MT; National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD 20892, United States., Roszko KL; National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD 20892, United States.

Publikováno v: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2024 Sep 02; Vol. 39 (9), pp. 1327-1339.

Familial tumoral calcinosis: a rare autosomal recessive disease.

Autor: Moran H; Endocrinology, Rutgers New Jersey Medical School, Newark, New Jersey, USA hm650@njms.rutgers.edu., Malvar M; Endocrinology, Rutgers New Jersey Medical School, Newark, New Jersey, USA., Yuksel S; Endocrinology, Rutgers New Jersey Medical School, Newark, New Jersey, USA., Bleich D; Endocrinology, Rutgers New Jersey Medical School, Newark, New Jersey, USA.

Publikováno v: BMJ case reports [BMJ Case Rep] 2024 Oct 11; Vol. 17 (10). Date of Electronic Publication: 2024 Oct 11.